Slone Partners Fills VP of Scientific Affairs Role for Cambridge Biomedical

03:00 EDT 20 Jun 2017 | PR Web

Seasoned industry expert to lead the organization’s science and technology initiatives.

(PRWEB) June 20, 2017

National executive search firm, Slone Partners, announces the placement of Linda Robbie, PhD, a well-versed leader with extensive assay development and biomarker expertise, as VP of Scientific Affairs at Cambridge Biomedical.

Established in 1997, Cambridge Biomedical is a Boston CRO specializing in bio-analytical assay development and sample testing services. The organization acts as a leading provider of customized assays for small and large molecules, biomarkers, and diagnostics.

In her new role, Dr. Robbie will serve as the head of science and innovation and will lead and direct all initiatives related to science and technology, clinical operations, and project management.

“Linda is an exceptional addition to our leadership team. Leveraging her unique people management skills and years of successful technology implementation, she will act as our key scientific point person interfacing with both our clients and internal teams. We are pleased to have worked with Slone Partners on this important search. Linda is truly a remarkable scientist and a perfect cultural fit for our organization,” said Chairwoman and CEO of Cambridge Biomedical, Barbara Osband.

Prior to joining Cambridge Biomedical, Dr. Robbie served as the Global Senior Director of Biomarkers and Translational Science at Q² Solutions Laboratories, a Quintiles-Quest Joint Venture, where she led assay development teams in the U.S. and overseas.

Dr. Robbie earned a Bachelor of Science, with honors, in Biochemistry from Heriot-Watt University in Edinburgh, Scotland, and a PhD, in Immunohematology from the Institute of Medical Science, Aberdeen University, Scotland.

About Slone Partners

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for the life sciences, diagnostics, clinical trials, contract research, therapeutics, healthcare information technology, and laboratory testing industries with offices in Boston, Washington, D.C. and San Francisco. Innovative, world-class organizations from across the nation have chosen Slone Partners to fill their key positions. To learn more about Slone Partners’ services, visit:

About Cambridge Biomedical

Cambridge Biomedical, based in Boston, MA, supports sponsors by developing customized assays for small and large molecules, biomarkers and other critical analytes, along with validation and sample testing in CLIA-certified and CAP-accredited, GLP/GCLP-compliant facilities. Cambridge Biomedical has extensive expertise in assay development, optimization and validation, and offers analytical support for PK/PD studies, biomarker development, clinical assay development, assay validation, specimen analysis and testing services. For more information, visit the website at, email info(at)cambridgebiomedical(dot)com or call 617.456.0700.

For the original version on PRWeb visit:


More From BioPortfolio on "Slone Partners Fills VP of Scientific Affairs Role for Cambridge Biomedical"

Quick Search


Relevant Topics

An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...